Jubilant Life Sciences receives ANDA approval for Darifenacin ER Tablets
Jubilant Life Sciences Ltd vide its letter dated October 13, 2016 has informed BSE regarding "Jubilant Life Sciences receives ANDA approval for Darifenacin ER Tablets". Issue of unsecured high yield bonds by the wholly-owned subsidiary Jubilant Pharma Limited (a Company incorporated under the laws of Singapore), outside India, under Regulation S of the U.S. Securities Act of 1933 (the US Securities Act)
Jubilant Life Sciences Ltd has informed BSE regarding "Issue of unsecured high yield bonds by the wholly-owned subsidiary Jubilant Pharma Limited (a Company incorporated under the laws of Singapore), outside India, under Regulation S of the U.S. Securities Act of 1933 (the US Securities Act)". Issue of unsecured high yield bonds by companies wholly owned subsidiary Jubilant Pharma Ltd
Jubilant Life Sciences Ltd has informed BSE about issue of unsecured high yield bonds by companies wholly owned subsidiary Jubilant Pharma Ltd ( a company incorporated under the law of Singapore), outside India, under regulation S of the U.S. Securities Act of 1933 (the ""US Securities Act") Jubilant arm gets TGA nod for lung scan drug
Jubilant Life Sciences today said its wholly-owned subsidiary has received approval from the Australian health regulator Therapeutic Goods Administration (TGA) for Lyophilised kit for the... Jubilant receives Australian approval for Lyophilized kit for the preparation of Tc 99m MAA Injection
Jubilant Life Sciences Ltd has submitted to BSE a copy of Press Release dated October 05, 2016 titled ''Jubilant receives Australian approval for Lyophilized kit for the preparation of Tc 99m MAA Injection". Credit Rating
Jubilant Life Sciences Ltd has informed BSE that the Company has received credit rating by India Ratings & Research Private Limited for Short Term Debt/Commercial Paper programme and Bank Loans Facilities. Jubilant Life Sciences rallies on USFDA nod for Ruby-Fill
The stock rallied 10% to Rs 676, also its record high on the BSE in intra-day trade. Jubilant receives USFDA approval for RUBY-FILL- Rubidium 82 Generator and Elution System
Jubilant Life Sciences Ltd has informed BSE regarding a Press Release dated October 03, 2016 titled "Jubilant receives USFDA approval for RUBY-FILL- Rubidium 82 Generator and Elution System". Jubilant Pharma raises $300 mn via bonds
Jubilant Life Sciences today said its subsidiary Jubilant Pharma has raised $300 million (approx Rs 1,998 crore) through issuance of five-year bonds to mainly retire debts.Our material wholly-owned... Issue of rated unsecured high yield bonds by the Company's wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore), outside India, under Regulation S of the U.S. Securities Act of 1933 (the US Securities Act)
Jubilant Life Sciences Ltd has informed BSE regarding "Issue of rated unsecured high yield bonds by our wholly-owned subsidiary, Jubilant Pharma Limited (a company incorporated under the laws of Singapore), outside India, under Regulation S of the U.S. Securities Act of 1933 (the US Securities Act)".